FTRD® meta-analysis: Transforming Colorectal Care

Meta-analysis of 29 studies shows FTRD® could set new standard for endoscopic treatment in the colorectum with high R0 rate of 81.8%

Key findings

• Pooled rate for R0 resection was 81.8% (95% CI 79-84.3%, I² 56%)
• Pooled rate sub analysis for R0 resection of

• Subepithelial lesions was 94.3% (95% CI 89.7-96.9%, I² 0%)
• Polyps ≤ 20 mm was 80.4% (95% CI 77.4-83.2% I² 0%)
• Polyps >20 mm was 59% (95% CI 40.1-75.6%, I² 76%)
• Adenocarcinomas (T1) was 76.2% (95% CI 68.6-82.4%, I² 72%)

Study details
• Of the 29 studies included in the meta-analysis, 27 focused on procedures using the FTRD
• Mean procedure duration was 52.6 min (95% CI 45.4-59.8, I² 98%)
• Pooled rate of technical success (reaching target lesion and macroscopic complete resection) was 87.1% (95% CI 85.1-88.9%, I² 39%)

Nabi Z, Samanta J, Dhar J, Mohan BP, Facciorusso A, Reddy DN. Device-assisted endoscopic full-thickness resection in colorectum: Systematic review and meta-analysis. Dig Endosc. 2024;36(2):116–28.

Pour plus d’informations cliniques et sur le produit, veuillez suivre les liens de notre site web sur les preuves cliniques ou le colonic FTRD^®.

Si vous souhaitez obtenir des conseils personnalisés sur nos produits, n’hésitez pas à contacter votre représentant local ou nous-mêmes.

Cordialement,
l’équipe du Service d’Information Scientifique d’Ovesco